These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 6394417)

  • 21. [Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis].
    Müller C; Zielinski CC
    Acta Med Austriaca; 1987; 14(5):115-8. PubMed ID: 3125713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
    Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
    Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased stable E rosette-forming cells in alcoholic liver disease.
    de Moura MC; Ramalho F
    Biomedicine; 1980 Nov; 33(7):220-1. PubMed ID: 6971655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lymphocytotoxicity in alcoholic hepatitis: evalutation of effector cells].
    Stefanini GF; Mariani E; Facchini A; Serra S; Miglio F
    Boll Soc Ital Biol Sper; 1979 Mar; 55(5):404-10. PubMed ID: 553595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of immature T-cell phenotypes in neonatal blood using monoclonal antibodies.
    Patterson JA; Griffiths-Chu S; Berger CL; Edelson RL; Chu AC
    Diagn Immunol; 1983; 1(3):205-10. PubMed ID: 6238751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycosis fungoides. Peripheral T cell subsets defined by specific monoclonal antibodies.
    Valsecchi R; Reseghetti A; Bontempelli M; Frigeni A; Cainelli T
    Dermatologica; 1984; 169(1):12-7. PubMed ID: 6236114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte cytotoxicity for autologous human hepatocytes in alcoholic liver disease.
    Izumi N; Hasumura Y; Takeuchi J
    Clin Exp Immunol; 1983 Oct; 54(1):219-24. PubMed ID: 6604608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies.
    Pfreundschuh M; Michel H; Parino G; Gram N; Stock C; Gause A; Hunstein W
    Z Rheumatol; 1981; 40(6):245-9. PubMed ID: 6460396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of suppressor T cell function and circulating immune complexes in alcoholic cirrhosis.
    Echevarría S; San Miguel G; Rodríguez de Lope C; Castillo E; Pons Romero F
    Allergol Immunopathol (Madr); 1985; 13(5):405-10. PubMed ID: 2934964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced concentration of hepatic alpha-tocopherol in patients with alcoholic liver cirrhosis.
    Bell H; Bjørneboe A; Eidsvoll B; Norum KR; Raknerud N; Try K; Thomassen Y; Drevon CA
    Alcohol Alcohol; 1992 Jan; 27(1):39-46. PubMed ID: 1580927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of circulating T-lymphocyte subsets in alcoholic liver disease by monoclonal antibodies: correlation with the absolute lymphocyte count.
    Chelazzi G; Piccinelli O; Senaldi G; Rossi D; Brugo MA
    Boll Ist Sieroter Milan; 1985; 64(2):131-4. PubMed ID: 3875355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgA deposition in liver in alcoholic liver disease. An index of progressive injury.
    Swerdlow MA; Chowdhury LN
    Arch Pathol Lab Med; 1984 May; 108(5):416-9. PubMed ID: 6370194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease.
    Orrego H; Kalant H; Israel Y; Blake J; Medline A; Rankin JG; Armstrong A; Kapur B
    Gastroenterology; 1979 Jan; 76(1):105-15. PubMed ID: 758131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the beta 1 chain (CD29) of integrins and CD45 in alcoholic liver disease. The VA Cooperative Study Group No. 275.
    Chedid A; Mendenhall CL; Moritz TE; French SW; Chen TS; Morgan TR
    Am J Gastroenterol; 1993 Nov; 88(11):1920-7. PubMed ID: 7694454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
    Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
    Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of t cell populations in alcoholic cirrhosis and chronic alcoholism.
    Fernandez LA; Laltoo M; Fox RA
    Clin Invest Med; 1982; 5(4):241-5. PubMed ID: 6984378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation factors V and VIII in relation to severity and outcome in acute alcoholic hepatitis.
    Pereira LM; Langley PG; Bird GL; Hayllar KM; Tredger JM; Williams R
    Alcohol Alcohol; 1992 Jan; 27(1):55-61. PubMed ID: 1580929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease.
    Izumi N; Sato C; Hasumura Y; Takeuchi J
    Clin Exp Immunol; 1985 Sep; 61(3):585-92. PubMed ID: 3907903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular immunity in alcohol-induced liver disease.
    Chelazzi G; Piccinelli O; Senaldi G; Rossi D; Brugo MA
    Acta Gastroenterol Belg; 1985; 48(2):111-7. PubMed ID: 3878651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.